TY - JOUR T1 - Review: topical mupirocin or fusidic acid may be more effective than oral antibiotics for limited non-bullous impetigo JF - Evidence Based Medicine JO - Evid Based Med SP - 176 LP - 176 DO - 10.1136/ebm.9.6.176 VL - 9 IS - 6 A2 - , Y1 - 2004/11/01 UR - http://ebm.bmj.com/content/9/6/176.abstract N2 - Koning S, Verhagen AP, van Suijlekom-Smit LW, et al. Interventions for impetigo. Cochrane Database Syst Rev 2004;(2):CD003261. 
 
 Q Which treatments are effective for impetigo? Clinical impact ratings Dermatology ★★★★★★☆ GP/FP/Primary care ★★★★★☆☆ Data sources: Cochrane Skin Group Specialised Trials Register (March 2002), Cochrane Central Register of Controlled Trials (Issue 1, 2002), National Research Register (2002), Medline (1966 to January 2003), EMBASE/Excerpta Medica (1980 to March 2000), LILACS (November 2001), and metaRegister of Controlled Trials on the Current Controlled Trials website; hand searches of Yearbook of Dermatology (1938–66) and Yearbook of Drug Therapy (1949–66); reference lists; and contact with trial authors and pharmaceutical companies. Study selection and assessment: published and unpublished randomised controlled trials (RCTs) in any language that assessed any intervention for impetigo (non-bullous, bullous, secondary, and impetiginised dermatoses) in patients with diagnosed impetigo, preferably confirmed by bacterial culture; studies that assessed patients with broadly defined bacterial skin infections or pyoderma were included if results for patients with impetigo were reported separately. 2 independent reviewers assessed the methodological quality of individual trials. Outcome: clinical cure … ER -